← Back to headlines
Pharma Stocks Rebound Amid Easing Patent Cliff Fears
Pharma stocks are rebounding due to cheap valuations and easing concerns over the patent cliff, according to UBS in a CNBC interview.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
